RE:RE:CC takeaways...
. "I think with MPH we are watching a very long-term strategy to build a specialty pharma." I believe you are correct. The Apicore investment creates synergies between MPH's current business and something from which they can capitalize on in the future. More is yet to come...wish I had invested more.